Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 16.11.16 in Vol 5, No 4 (2016): Oct-Dec

This paper is in the following e-collection/theme issue:

Works citing "Pixel or Paper? Validation of a Mobile Technology for Collecting Patient-Reported Outcomes in Rheumatoid Arthritis"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.5631):

(note that this is only a small subset of citations)

  1. Burcal CJ, Chung S, Johnston ML, Rosen AB. Does the Method of Administration Affect Reliability of the Foot and Ankle Ability Measure?. Journal of Sport Rehabilitation 2020;29(7):1038
    CrossRef
  2. Rosen AB, Johnston M, Chung S, Burcal CJ. The reliability and validity of a digital version of the Cumberland Ankle Instability Tool. Disability and Rehabilitation 2021;43(12):1738
    CrossRef
  3. Dixon WG, Michaud K. Using technology to support clinical care and research in rheumatoid arthritis. Current Opinion in Rheumatology 2018;30(3):276
    CrossRef
  4. Jung M, Lee S, Kim J, Kim H, Ko B, Son BH, Ahn S, Park YR, Cho D, Chung H, Park HJ, Lee M, Lee JW, Chung S, Chung IY. A Mobile Technology for Collecting Patient-Reported Physical Activity and Distress Outcomes: Cross-Sectional Cohort Study. JMIR mHealth and uHealth 2020;8(5):e17320
    CrossRef
  5. Gandrup J, Yazdany J. Using Health Information Technology to Support Use of Patient-Reported Outcomes in Rheumatology. Rheumatic Disease Clinics of North America 2019;45(2):257
    CrossRef
  6. Teixeira Neto NC, Lima YL, Almeida GPL, Bezerra MA, Lima PODP, de Oliveira RR. Physiotherapy Questionnaires App to Deliver Main Musculoskeletal Assessment Questionnaires: Development and Validation Study. JMIR Rehabilitation and Assistive Technologies 2018;5(1):e1
    CrossRef
  7. Psotka MA, Abraham WT, Fiuzat M, Filippatos G, Lindenfeld J, Ahmad T, Bhatt AS, Carson PE, Cleland JG, Felker GM, Januzzi JL, Kitzman DW, Leifer ES, Lewis EF, McMurray JJ, Mentz RJ, Solomon SD, Stockbridge N, Teerlink JR, Vaduganathan M, Vardeny O, Whellan DJ, Wittes J, Anker SD, O'Connor CM. Conduct of Clinical Trials in the Era of COVID-19. Journal of the American College of Cardiology 2020;76(20):2368
    CrossRef
  8. Chahal S, Biln N, Clarke B. Patient Perspectives on a Digital Mobile Health Application for RA. Open Access Rheumatology: Research and Reviews 2021;Volume 13:63
    CrossRef
  9. Chevallard M, Belloli L, Ughi N, Adinolfi A, Casu C, Di Cicco M, Filippini DA, Muscarà M, Schito E, Verduci E, Gentile MG, Di Rosa B, Zoppini L, Carli C, Destefani C, Luisi A, Vincenti EM, Epis OM. Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting. Rheumatology International 2021;41(7):1253
    CrossRef
  10. Uhrenholt L, Christensen R, Dreyer L, Schlemmer A, Hauge E, Krogh N, Abildtoft M, Taylor P, Kristensen S. Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study. Scandinavian Journal of Rheumatology 2022;51(1):25
    CrossRef
  11. Uhrenholt L, Høstgaard S, Pedersen JF, Christensen R, Dreyer L, Leffers HCB, Taylor PC, Strand V, Jacobsen S, Voss A, Gregersen JW, Kristensen S. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study. Lupus 2021;30(13):2124
    CrossRef
  12. Psotka MA, Abraham WT, Fiuzat M, Filippatos G, Lindenfeld J, Ahmad T, Felker GM, Jacob R, Kitzman DW, Leifer ES, Lewis EF, Mentz RJ, Nkulikiyinka R, Ni W, Schaber DE, Sharma A, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Whellan DJ, Wittes J, Anker SD, O’Connor CM. Functional and Symptomatic Clinical Trial Endpoints. JACC: Heart Failure 2022;10(12):889
    CrossRef
  13. Taylor PC, Askari A, Choy E, Ehrenstein MR, Else S, Nisar MK. Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease. BMC Medicine 2023;21(1)
    CrossRef